Attorney Discusses Cosmetic Trespasses On Drug Turf Leading To FDA Action
• By Louisa Tavlas
The line that divides drugs from personal care is "fuzzy," but companies can begin to understand what marketing claims are acceptable to FDA by learning from the mistakes of others, Ivan Wasserman, partner at Manatt, Phelps & Phillips, suggests
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
